PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date.
Alessandro CherubiniElia CasiratiMelissa TomasiLuca Vittorio ValentiPublished in: Expert opinion on therapeutic targets (2021)
p.I148M, responsible for a large fraction of disease susceptibility.
Keyphrases